AllDocs -> cancers

Chapter 19: Laryngeal cancer 183 Laryngeal cancer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

LARYNGEAL & HYPOPHARYNGEAL CANCER - All Sections LARYNGEAL & HYPOPHARYNGEAL CANCER What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells develop because of damage to DNA. This substance is in every cell and directs all its activities. Most of the time when DNA ...

Trends in laryngeal cancer mortality in Europe Cristina Bosetti 1 * , Werner Garavello 1,2 , Fabio Levi 3 , Franca Lucchini 3 , Eva Negri 1 and Carlo LaVecchia 1,4 1 Istituto di Ricerche Farmacologiche ‘‘Mario Negri,’’ Milan, Italy 2 Clinica Otorinolaringoiatrica, DNTB, Universita` Milano-Bicocca, Monza, Italy 3 Registre Vaudois des Tumeurs, Institut Universitaire de M edecine Sociale et Pr eventive, Lausanne, Switzerland 4 Istituto di Statistica Medica e Biometria, Universita` degli Studi di Milano, Milan, Italy After a steady increase since the 1950s, laryngeal cancer mortality had tended to level off since the early 1980s in men from most Euro- pean countries. To update trends in laryngeal cancer mortality in Europe, age-standardized (world standard) mortality ...

HISTORICAL CASE REPORT Giacomo Puccini's laryngeal cancer : a Belgian recollection Tainmont J. W. Churchill Avenue 172, 1180 Brussels, Belgium Introduction and Aim Until now, it does not seem that Belgian ENT specialists were particularly interested concerning the treatment of Giacomo Puccini's laryngeal cancer applied by the late dr Louis Ledoux from Brussels. We decided to present this paper at once to pay homage to the latter and to enrich Puccini's memory with a specifically Belgian contribution. Case report A chronicle of the last weeks of Puccini's life is presented: 4th of November 1924: arrival in Brussels; 7th: radium collar; 24th: fenestration of the thyroid cartilage and implantation of 7 radium needles in the tumour. 29th: death. This is enriched by some details of Belgian origin. At the same time, we propose a reminder of the scientific contribution of dr Ledoux to the 1920's medical ...

85 An evaluation of laryngeal cancer morbidity time trends in Lithuania Roczniki Akademii Medycznej w Bialymstoku · Vol. 48, 2003 · Annales Academiae Medicae Bialostocensis ADDRESS FOR CORRESPONDENCE: Lilija Jasevi ien , PhD, Thoracic Surgery Department, Head and Neck Division Institute of Oncology of Vilnius University Santari ki – 1, Vilnius, Lithuania tel.: +370 687 95420 fax: +370 5278766 e-mail: irmantas.jasevicius@vuw.lt Received 22.04.2003 Accepted 29.05.2003 Abstract Purpose: To make assessments of the rates of cases of larynx cancer in Lithuania in the years 1978-2001 as well as possible trends of changes in the future. Material and methods: The data contained in the Lithu- anian Cancer Register for the period 1978-2001 about new cases as well as the data compiled by the Lithuanian Department of Statistics on the average ...

350 J Med Assoc Thai Vol. 89 No. 3 2006 Correspondence to : Ratanaanekchai T, Department of Otolaryngology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand. J Med Assoc Thai 2006; 89 (3): 350-3 Full text. e-Journal: http://www.medassocthai.org/journal Recurrent Laryngeal Cancer after Surgical Treatment Teeraporn Ratanaanekchai MD*, Wisoot Reechaipichitkul MD* * Department of Otolaryngology, Faculty of Medicine, Khon Kaen University, Khon Kaen Objective: Study the presentation pattern of recurrent laryngeal cancer after surgical treatment. Material and Method: The patterns of recurrent laryngeal cancer after surgical treatment were reviewed: 17 cases were included in the present study. Results: The most common encountered cancers among the recurrent cases were transglottic (59%), supra- glottic (35%), and ...

Fifth International Laryngeal Cancer Conference State-of-the-Art in Surgical and Non-surgical Organ Preservation for Laryngeal and Pharyngeal Carcinoma Fifth International Laryngeal Cancer Conference State-of-the-Art in Surgical and Non-surgical Organ Preservation for Laryngeal and Pharyngeal Carcinoma CALL FOR POSTER ABSTRACTS Thursday & Friday March 2-3, 2006 Didactic and Poster Presentation The Rittenhouse Hotel 210 West Rittenhouse Square Philadelphia, PA Saturday March 4, 2006 Hands-on Laser, Robotic Surgery and Cadaver Dissection Campus of the University of Pennsylvania Medical Center 3400 Spruce Street Philadelphia, PA This conference is supported in part by an educational grant from Integral PET Associates, LLC. Presented ...

laryngeal cancer Organ Preservation for Laryngeal Cancer Adam Ray, MD Division of Otolaryngology-Head and Neck Surgery SIU School of Medicine Objectives Discuss laryngeal preservation strategies designed and researched in landmark studies Compare and contrast these studies and their outcomes Discuss organ preservation vs function Future trial with novel agents What this means for training programs Introduction 12,000 new cases per year Single modality treatment for early staged glottic cancers 60-65% glottic 30-35% supraglottic 5% subglottic Advanced staged glottic tumors can require multi-modality therapy Several trials have demonstrated organ preservation without compromise in survival ...

Update on the endoscopic management of laryngeal cancer Henry T. Hoffman and John Buatti Purpose of review This update addressing the endoscopic management of laryngeal cancer presents new data published after January 2003. This new information is interpreted in the context of contemporary management principles established before 2003. Recent findings Endoscopic techniques in the management of laryngeal cancer continue to undergo modifications designed to improve oncologic efficacy in a manner that maximally preserves function. The modifications reported over the past two years have included the introduction of new diagnostic techniques, new surgical approaches, new endoscopic equipment, and new management philosophies. Summary Endoscopic resection has become a widely accepted and commonly employed management option in the treatment of laryngeal ...

) 1100 Discussion COFFEE 1125 - 1145 Radiotherapy or Partial laryngectomy for early laryngeal cancers? Chair Dr JS Tobias / Mr P Rhys Evans 1145 - 1310 1145 DXT: doses, fractionation, acceptable delay; morbidity Dr CG Kelly (Page 21) 1205 High quality imaging for treatment planning Mr JC Watkinson (Page 31) 1225 Partial Laryngectomy Mr G Buckley (Page 36) 1245 Discussion LUNCH 1310-1400 Afternoon: Advanced Cancer Beyond Total Laryngectomy Chairs Prof N Stafford / Dr RH MacDougall 1400- 1500 1400 The case for primary radiotherapy in T3 lesions Dr P Dyson (Page 48) 1415 Discussion ...

CASE REPORT Laryngeal Zoster Mimicking a Laryngeal Cancer Eisaku Higuchi, MD, Yuji Nakamaru, MD, Ryuichiro Ohwatari, MD, Tomoharu Sakashita, MD, Yasushi Mesuda, MD, Akihiro Homma, MD, Yasushi Furuta, MD, Satoshi Fukuda, MD, Sapporo, Japan H erpes zoster is a viral cutaneous eruption caused by varicella-zoster virus (VZV) infection. Clinically, her- pes zoster appears as a unilateral cluster of vesicular lesions with surrounding erythema in the dermatomal distribution of 1 or more adjacent sensory nerves. 1 The most common manifestation of herpes zoster in the head and neck region is Ramsay Hunt syndrome. This is a well-known VZV- associated disease characterized by the dysfunction of cra- nial nerves VII and VIII causing acute peripheral facial palsy, hearing loss, and zoster eruption around the ears. 2 Less commonly, the reactivation ...

The management of early laryngeal cancer : options for patients and therapists Gary Back and Sanjai Sood Purpose of review To evaluate the optimal treatment of early laryngeal cancer and to highlight new developments. Recent findings The use of hyperfractionation and acceleration of radiotherapy may result in improved outcomes for patients with respect to cancer cure and preservation of the larynx. Options for surgical treatment include endoscopic resection and open partial laryngectomy. The use of endoscopic vertical partial laryngectomy may overcome the difficulties encountered in exposure with transoral laser resection of anterior commissure tumors. The microdebrider may be a useful alternative to CO 2 laser in endoscopic resection in selected cases. A further treatment option that shows promising results is photodynamic therapy, which has some important ...

Treatment of Laryngeal Cancer 116 J HK Coll Radiol 2001;4:116-118 J HK Coll Radiol 2001;4:116-118 INVITED REVIEW The two major modalities for treating laryngeal cancer are surgery and radiation therapy, with the selection of treatment depending on the location of the tumour and the stage of the disease. Computed tomography (CT) and/or magnetic resonance imaging (MRI) of the neck and larynx are routinely used to evaluate patients with laryngeal cancers. Findings from these tests and from physical examination are used to determine the clinical stage of disease. The two major staging systems are the American Joint Committee on Cancer (AJCC) system 1 and the Inter- national Union Against Cancer (UICC) staging. 2 Both systems have recently been modified and are essentially the same. A specific change that occurred in the most ...

©2005 American Academy of Otolaryngology—Head and Neck Surgery 1 "Listen to your voice! It may be telling you something!" www.entnet.org/news/VoiceDay.cfm 2005 Laryngeal cancer is not as well known by the general public as some other types of cancer , yet it is not a rare disease. The American Cancer Society estimates that in 2005 almost 10,000 new cases of laryngeal cancer will be diagnosed, and close to 3,800 people will die from laryngeal cancer in the United States. Even for survivors, the consequences of laryngeal cancer can be severe with respect to voice, breathing, or swallowing. It is fundamentally a preventable disease though, since the primary risk factors for laryngeal cancer are associated with modifiable behaviors. Risk Factors Associated With Laryngeal Cancer Development of laryngeal cancer is a process that involves many factors, ...

VOICEPROBLEM.ORG t h e v o i c e p r o b l e m w e b s i t e voice disorders laryngeal advanced cancer Page 2 Highlights Symptoms of Advanced Laryngeal Cancer Red Flag Early Detection Is Critical for Tumor Control The symptoms listed below indicate a need for prompt and thorough evaluation by a physician. Most Common Symptoms Hoarseness Swallowing or breathing difficulty Ear pain Unintended weight loss of greater than 10 pounds over six months in a smoker Other Symptoms Pain or difficulty swallowing Noisy breathing Voice changes (hoarseness) that persist for more than one month In addition, a non-tender mass in the neck that persists for more than one or two months, particularly in someone over 40 years of age with a history of smoking, should be promptly evaluated. Consideration ...

VOICEPROBLEM.ORG t h e v o i c e p r o b l e m w e b s i t e voice disorders laryngeal atypia and early cancer Page 2 Laryngeal Atypia and Early Cancer : Highlights Vocal Fold Atypia Vocal fold atypia often appear as whitish or reddish lesions on the vocal fold surface, and are comprised of abnormal- looking cells that are not cancerous. Thought to be a prequel to cancer , atypia are usually considered as pre-cancerous or pre-malignant. Early Vocal Fold Cancer Early vocal fold cancer also appear as whitish or reddish lesions, but have abnormal-looking cells that have invaded the boundary of the top layer of the vocal fold. Early cancer may affect one or both vocal folds and are often referred to as T1 or T2 type vocal fold cancers that have not spread to neck lymph nodes or elsewhere in the body. Symptoms Do Not Distinguish ...

262 Rogowski M, et al. 263 Loss of heterozygosity in laryngeal cancer Abstract Purpose: Head and neck cancers account for about 6% of all human cancers. Molecular changes leading to the disease development and progression still remain not fully explained. Examination of loss of heterozygosity (allelic loss, LOH) using the specific microsatellite markers is a method of choice in assessing tumour suppressor genes (TSGs) localisation in human genome. Material and methods: The study was performed in a group of 46 male patients, aged 42 - 77 years. Forty three patients underwent total laryngectomy with lymph nodec- tomy, two patients – chordectomy and one patient – partial laryngectomy. Tumour tissue specimens and reference periphereal blood samples were obtained during surgical resections. Standard methods were used for DNA isolation. Fluores- ...

Survey of Laryngeal Cancer at SBUH comparing 108 cases seen here from 1998 – 2002 to the NCDB of 9,256 cases diagnosed nationwide in 2000 Stony Brook University Hospital Cancer Program Annual Report 2002-2003 Page 2 Gender distribution for 108 cases of laryngeal cancer at SBUH from 1998 to 2002 compared to NCDB 0% 10% 20% 30% 40% 50% 60% 70% 80% Men Women SBUH NCDB Page 3 Age at Diagnosis for 108 cases of laryngeal cancer at SBUH from 1998 to 2002 compared to NCDB 0% 5% 10% 15% 20% 25% 30% 35% >29 30- 39 40- 49 50- 59 60- 69 70- 79 80+ SBUH NCDB ...

MJA Vol 176 4 February 2002 113 MEDICINE AND THE LAW The Medical Journal of Australia ISSN: 0025-729X 4 February 2002 176 _ 113-116 ©The Medical Journal of Australia 2002 www.mja.com.au MEDICINE AND THE LAW I N A RECENT DECISION of the Supreme Court of New South Wales, Sharp v Port Kembla RSL Club Ltd , an employee recovered damages from her employer on the basis that exposure to environmental tobacco smoke (ETS) in the course of her employment caused, or materially contributed to, the development of laryngeal cancer (see Box 1 for the plaintiff’s occupational and clinical history). The plaintiff had brought her claim against two employers; one claim was settled out of court and the other proceeded. The decision is noteworthy not so much because it extends medicolegal recognition of cancer causation by ETS beyond the lung, but because ...

INCIDENCE, SURVIVAL, DIAGNOSTIC DELAYS AND PROGNOSTIC FACTORS IN LARYNGEAL CANCER HEIKKI TEPPO Department of Otorhinolaryngology, University of Oulu OULU 2003 Page 2 Page 3 HEIKKI TEPPO INCIDENCE, SURVIVAL, DIAGNOSTIC DELAYS AND PROGNOSTIC FACTORS IN LARYNGEAL CANCER Academic Dissertation to be presented with the assent of the Faculty of Medicine, University of Oulu, for public discussion in the Auditorium 7 of the University Hospital of Oulu, on October 31th, 2003, at 12 noon. OULUN YLIOPISTO, OULU 2003 Page 4 Copyright © 2003 University of Oulu, 2003 Supervised by Docent Olli-Pekka Alho Reviewed by Docent Heikki Minn Docent Jukka Virtaniemi ISBN 951-42-7126-2 (URL: http://herkules.oulu.fi/isbn9514271262/) ...

A rchivum Immunologiae et Therapiae Experimentalis, 1999, 4 ¡ 7 , ¢ 161–168 P £ L ISSN 0004-069X Tumor Infiltrating Lymphocytes in HLA + and HLA – Laryngeal Cancer – Quantitative Approach G ¤ . Dworacki et al.: HLA and TIL in Laryngeal Carcinoma G RZEGORZ D W ¥ ORACKI 1 , A L ¦ EKSANDRA K RUK -Z A GAJEWSKA 2 , E LZ ? BIETA J EZ ? EWSKA 1 , J A N S I § KORA 1 and J A N Z ? EROMSKI 1 1 Department ...

INTRODUCTION alignant diseases are diseases with high case-fatality rates. In overall cause of mortality they are second, following the cardiovascular diseases, constituting 18% of all diseases. Laryngeal carcinoma is not a disease with high frequency, and although the larynx is part of the respiratory tract, malignant tumors at this location are less frequent than the carcinomas of the lower part of the respiratory tract. Laryngeal cancer consti- tutes 1-3% of all malignant tumors, but in the head and neck region it constitutes 20% of all tumors and is the most frequent in this region. The incidence of malignant tumor of the larynx in males is on the sixth place in the province of Vojvodina, while in females, it is not in the ten most frequent (1). The province of Vojvodina was included in the registrations of the malignant diseases in the world as early as 1904. However, the data of malignant ...